121 related articles for article (PubMed ID: 9525666)
1. Efficient expression and rapid purification of human T-cell leukemia virus type 1 protease.
Ding YS; Owen SM; Lal RB; Ikeda RA
J Virol; 1998 Apr; 72(4):3383-6. PubMed ID: 9525666
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.
Saiga A; Tanaka T; Orita S; Sato A; Sato S; Hachisu T; Abe K; Kimura Y; Kondo Y; Fujiwara T
Arch Virol; 1993; 128(3-4):195-210. PubMed ID: 8435041
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli.
Kobayashi M; Ohi Y; Asano T; Hayakawa T; Kato K; Kakinuma A; Hatanaka M
FEBS Lett; 1991 Nov; 293(1-2):106-10. PubMed ID: 1959638
[TBL] [Abstract][Full Text] [Related]
4. Substrates and inhibitors of human T-cell leukemia virus type I protease.
Ding YS; Rich DH; Ikeda RA
Biochemistry; 1998 Dec; 37(50):17514-8. PubMed ID: 9860866
[TBL] [Abstract][Full Text] [Related]
5. Expression of human T-cell leukemia virus type I protease in Escherichia coli.
Hayakawa T; Misumi Y; Kobayashi M; Ohi Y; Fujisawa Y; Kakinuma A; Hatanaka M
Biochem Biophys Res Commun; 1991 Dec; 181(3):1281-7. PubMed ID: 1764078
[TBL] [Abstract][Full Text] [Related]
6. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
Hrusková-Heidingsfeldová O; Bláha I; Urban J; Strop P; Pichová I
Leukemia; 1997 Apr; 11 Suppl 3():45-6. PubMed ID: 9209292
[TBL] [Abstract][Full Text] [Related]
7. Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.
Kádas J; Weber IT; Bagossi P; Miklóssy G; Boross P; Oroszlan S; Tözsér J
J Biol Chem; 2004 Jun; 279(26):27148-57. PubMed ID: 15102858
[TBL] [Abstract][Full Text] [Related]
8. Expression and characterization of human foamy virus proteinase.
Fenyöfalvi G; Bagossi P; Copeland TD; Oroszlan S; Boross P; Tözsér J
FEBS Lett; 1999 Dec; 462(3):397-401. PubMed ID: 10622733
[TBL] [Abstract][Full Text] [Related]
9. Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.
Daenke S; Schramm HJ; Bangham CR
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2233-9. PubMed ID: 8077922
[TBL] [Abstract][Full Text] [Related]
10. The protease of human T-cell leukemia virus type-1 is a potential therapeutic target.
Tözsér J; Weber IT
Curr Pharm Des; 2007; 13(12):1285-94. PubMed ID: 17504236
[TBL] [Abstract][Full Text] [Related]
11. Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase.
Louis JM; Oroszlan S; Tözsér J
J Biol Chem; 1999 Mar; 274(10):6660-6. PubMed ID: 10037763
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and biochemical characterisation of simian immunodeficiency virus proteinase mutant.
Corr BR; Wilderspin AF
Biochem Soc Trans; 1994 Feb; 22(1):55S. PubMed ID: 8206284
[No Abstract] [Full Text] [Related]
13. C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.
Kádas J; Boross P; Weber IT; Bagossi P; Matúz K; Tözsér J
Biochem J; 2008 Dec; 416(3):357-64. PubMed ID: 18636969
[TBL] [Abstract][Full Text] [Related]
14. Purification of crystallizable recombinant SIVmac251-32H proteinase.
Sugrue RJ; Almond N; Kitchin P; Richardson SM; Wilderspin AF
Protein Expr Purif; 1994 Feb; 5(1):76-83. PubMed ID: 8167477
[TBL] [Abstract][Full Text] [Related]
15. Improved purification protocol for wild-type and mutant human foamy virus proteases.
Boross P; Tözsér J; Bagossi P
Protein Expr Purif; 2006 Apr; 46(2):343-7. PubMed ID: 16243539
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum Plasmepsin V (PfPMV): Insights into recombinant expression, substrate specificity and active site structure.
Boonyalai N; Sittikul P; Yuvaniyama J
Mol Biochem Parasitol; 2015 May; 201(1):5-15. PubMed ID: 25986559
[TBL] [Abstract][Full Text] [Related]
17. Development of [Ile⁴⁰]HTLV-I protease inhibition assay using novel fluorogenic and chromogenic substrate.
Kumada HO; Nguyen JT; Kakizawa T; Hidaka K; Kimura T; Hayashi Y; Kiso Y
J Pept Sci; 2011 Aug; 17(8):569-75. PubMed ID: 21574213
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human T-cell leukemia virus type I integrase expressed in Escherichia coli.
Müller B; Kräusslich HG
Eur J Biochem; 1999 Jan; 259(1-2):79-87. PubMed ID: 9914478
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of aspartic proteinase from sunflower seeds.
Park H; Yamanaka N; Mikkonen A; Kusakabe I; Kobayashi H
Biosci Biotechnol Biochem; 2000 May; 64(5):931-9. PubMed ID: 10879461
[TBL] [Abstract][Full Text] [Related]
20. Understanding HTLV-I protease.
Shuker SB; Mariani VL; Herger BE; Dennison KJ
Chem Biol; 2003 May; 10(5):373-80. PubMed ID: 12770819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
